NCT00723840

Assessment of the Social Cost of Crohn's Disease: Economic and Quality of Life Aspects (Study P04560)

Assessment of the Social Cost of Crohn's Disease (COsto Sociale Della Malattia di CrOhn - COSMO): Economic and Quality of Life Aspects

• Status: Completed
• Phase: —
• Study type: Observational
• Enrollment: 245 (actual)
• Sponsor: Merck Sharp & Dohme LLC · Industry
• Sex: All
• Age: 18 Years – 70 Years
• Healthy volunteers: Not accepted

Summary

This observational study will evaluate the social cost and quality of life of participants who have had Crohn's Disease for at least 6 months and have active disease despite drug therapy. Participants are followed for a total of 18 months.

Detailed description

Participants for this study will be enrolled from 25 gastroenterology sites, even spread across Italy. Each center will enroll between 10 and 40 participants each.

Conditions

• Inflammatory Bowel Disease
• Crohn's Disease

Interventions

Type	Name	Description
OTHER	Observational Studies: participants treated according to the real clinical practice.	No intervention was administered to the participants specifically for the purpose this study. Participant could be on any drug therapy.

Timeline

• Start date: 2006-09-01
• Primary completion: 2009-12-01
• Completion: 2009-12-01
• First posted: 2008-07-29
• Last updated: 2015-07-30
• Results posted: 2011-04-29